| Acute Leukemia |
1 |
1 |
| Child |
0 |
0.98 |
| Obesity |
0 |
0.68 |
| Biologic Therapy |
0 |
0.45 |
| Leukemia |
0 |
0.38 |
| Toxicology |
0 |
0.36 |
| Cancer |
0 |
0.35 |
| Chemotherapy |
0 |
0.27 |
| Psychosocial |
0 |
0.27 |
| Young Adult |
0 |
0.27 |
| Acute Lymphoblastic Leukemia |
0 |
0.99 |
| Adolescent Medicine |
0 |
0.18 |
| Hematology |
0 |
0.18 |
| Adherence |
0 |
0.15 |
| Adverse Effects |
0 |
0.09 |
| CAR-T |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Face |
0 |
0.09 |
| Fertility |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Immunotherapy |
0 |
0.09 |
| Infertility |
0 |
0.09 |
| Insurance |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Spine |
0 |
0.09 |
| Tolerance |
0 |
0.09 |